U.S. Physical Therapy, Inc. (NYSE:USPH) Stock Has Average Target Price of $98.25 According to Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $98.25.

USPH has been the topic of several research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. Citizens Jmp reiterated a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. JPMorgan Chase & Co. boosted their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. Barrington Research upped their price target on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of USPH. BlackRock Inc. purchased a new stake in shares of U.S. Physical Therapy in the second quarter valued at approximately $155,505,000. William Blair Investment Management LLC purchased a new position in U.S. Physical Therapy during the 2nd quarter worth $30,013,000. Bank of America Corp DE purchased a new position in U.S. Physical Therapy during the 2nd quarter worth $19,381,000. Bank of New York Mellon Corp purchased a new position in U.S. Physical Therapy during the 2nd quarter worth $9,087,000. Finally, Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 6.5% during the 1st quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock valued at $62,729,000 after purchasing an additional 50,717 shares in the last quarter.

U.S. Physical Therapy Trading Down 3.6%

USPH opened at $82.68 on Tuesday. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 486.39, a P/E/G ratio of 2.18 and a beta of 1.12. The stock’s 50 day moving average price is $80.06 and its 200-day moving average price is $73.32. U.S. Physical Therapy has a one year low of $58.19 and a one year high of $93.50. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The business had revenue of $214.06 million during the quarter, compared to analysts’ expectations of $211.36 million. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, equities analysts forecast that U.S. Physical Therapy will post 2.89 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were given a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Friday, August 21st. U.S. Physical Therapy’s payout ratio is 1,082.35%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc is a healthcare company that operates outpatient physical therapy clinics and manages physical therapy practices throughout the United States. Its clinics provide rehabilitation services for patients recovering from injuries, surgeries, illnesses and chronic conditions, with treatment commonly focused on restoring mobility, strength and function.

The company operates both physical therapy facilities and physical therapy management partnerships. In addition to traditional outpatient rehabilitation, its services include sports medicine, workers’ compensation care and related programs designed to help employers prevent and manage workplace injuries.